EW biotech catalysts & pipeline

EDWARDS LIFESCIENCES CORP · Data as of 2026-10-25

Upcoming catalysts

CLASP IITR trial — Conference presentation

Oct 31–Nov 3

Also in the fourth quarter, Edwards continues to expect CLASP IITR trial results to be presented at TCT, and the launch of the PASCAL system in the U.S. for tricuspid patients.

Source filing

PASCAL — Conference presentation

Oct 31–Nov 3

Expected clinical presentations at TCT: PROGRESS and CLASP IITR

Source filing

PROGRESS trial — Conference presentation

Oct 31–Nov 3

The clinical community will learn more about the clinical relevance of treating these patients with TAVR when the PROGRESS trial results are presented at TCT later this year.

Source filing

SAPIEN TAVR — Conference presentation

Oct 31–Nov 3

Later this year, results of the PROGRESS trial studying patients with moderate AS will be presented at the TCT conference.

Source filing

TAVR — Conference presentation

Oct 31–Nov 3

Expected clinical presentations at TCT: PROGRESS and CLASP IITR

Source filing

Explore the free biotech catalyst calendar